WVE logo

Wave Life Sciences (WVE) Long Term Liabilities

Annual Total Long Term Liabilities

$48.88 M
-$71.08 M-59.25%

December 31, 2023


Summary


Performance

WVE Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherWVEbalance sheetmetrics:

Quarterly Long Term Liabilities

$46.14 M
+$6.97 M+17.79%

September 30, 2024


Summary


Performance

WVE Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherWVEbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

WVE Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-59.3%-5.6%
3 y3 years-35.2%-5.6%
5 y5 years-47.2%-5.6%

WVE Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-59.3%at low-72.8%+17.8%
5 y5-year-59.3%at low-72.8%+17.8%
alltimeall time-59.3%>+9999.0%-73.0%>+9999.0%

Wave Life Sciences Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$46.14 M(+17.8%)
Jun 2024
-
$39.17 M(-11.0%)
Mar 2024
-
$44.01 M(-10.0%)
Dec 2023
$48.88 M(-59.3%)
$48.88 M(-65.2%)
Sep 2023
-
$140.42 M(-0.7%)
Jun 2023
-
$141.48 M(-16.5%)
Mar 2023
-
$169.42 M(+41.2%)
Dec 2022
$119.96 M(+8.7%)
$119.96 M(-1.5%)
Sep 2022
-
$121.77 M(+2.9%)
Jun 2022
-
$118.29 M(+8.6%)
Mar 2022
-
$108.93 M(-1.3%)
Dec 2021
$110.31 M(+46.3%)
$110.31 M(-20.6%)
Sep 2021
-
$138.97 M(+0.8%)
Jun 2021
-
$137.85 M(-2.3%)
Mar 2021
-
$141.15 M(+87.1%)
Dec 2020
$75.42 M(-26.3%)
$75.42 M(-18.2%)
Sep 2020
-
$92.16 M(-6.0%)
Jun 2020
-
$97.99 M(-0.9%)
Mar 2020
-
$98.83 M(-3.5%)
Dec 2019
$102.36 M
$102.36 M(+3.4%)
DateAnnualQuarterly
Sep 2019
-
$99.03 M(-2.2%)
Jun 2019
-
$101.24 M(-0.6%)
Mar 2019
-
$101.88 M(+10.1%)
Dec 2018
$92.55 M(+285.0%)
$92.55 M(+0.4%)
Sep 2018
-
$92.18 M(-46.0%)
Jun 2018
-
$170.67 M(+608.9%)
Mar 2018
-
$24.07 M(+0.1%)
Dec 2017
$24.04 M(+35.1%)
$24.04 M(+13.9%)
Sep 2017
-
$21.11 M(-3.9%)
Jun 2017
-
$21.96 M(+7.9%)
Mar 2017
-
$20.35 M(+14.4%)
Dec 2016
$17.79 M(+119.3%)
$17.79 M(+2.2%)
Sep 2016
-
$17.41 M(+13.0%)
Jun 2016
-
$15.41 M(+87.3%)
Mar 2016
-
$8.23 M(+1.4%)
Dec 2015
$8.12 M(>+9900.0%)
$8.12 M(-88.5%)
Sep 2015
-
$70.64 M(>+9900.0%)
Jun 2015
-
$141.00 K(+386.2%)
Dec 2014
$29.00 K(-19.4%)
$29.00 K
Dec 2013
$36.00 K
-

FAQ

  • What is Wave Life Sciences annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Wave Life Sciences?
  • What is Wave Life Sciences annual total long term liabilities year-on-year change?
  • What is Wave Life Sciences quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Wave Life Sciences?
  • What is Wave Life Sciences quarterly long term liabilities year-on-year change?

What is Wave Life Sciences annual total long term liabilities?

The current annual total long term liabilities of WVE is $48.88 M

What is the all time high annual total long term liabilities for Wave Life Sciences?

Wave Life Sciences all-time high annual total long term liabilities is $119.96 M

What is Wave Life Sciences annual total long term liabilities year-on-year change?

Over the past year, WVE annual total long term liabilities has changed by -$71.08 M (-59.25%)

What is Wave Life Sciences quarterly total long term liabilities?

The current quarterly long term liabilities of WVE is $46.14 M

What is the all time high quarterly long term liabilities for Wave Life Sciences?

Wave Life Sciences all-time high quarterly total long term liabilities is $170.67 M

What is Wave Life Sciences quarterly long term liabilities year-on-year change?

Over the past year, WVE quarterly total long term liabilities has changed by -$2.74 M (-5.61%)